Clinical trial Recruiting at 1 site Interventional Ages 25 to 75

Effects of Time-Restricted Eating on Cardiometabolic Health

Official title: The Effect of Time-Restricted Eating in Cardiometabolic Health

Run by Cambridge University Hospitals NHS Foundation Trust · NCT05866406 · Data updated 2026-11-12

This study is testing if eating only during a 9-hour window each day can help people with obesity and prediabetes improve their heart and metabolic health over 12 weeks.

More Obesity trials

Quick facts

Study typeInterventional
Ages25 Years to 75 Years
SexAll
Enrollment100 (estimated)
SponsorCambridge University Hospitals NHS Foundation Trust
Academic / other
Locations1 site (Cambridge)
StatusRecruiting
StartedNovember 1, 2023
Main results expectedJune 30, 2028
Study endsAugust 31, 2028
Registry record updatedMay 28, 2026
Trial IDNCT05866406 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 25-75 with a body mass index between 27-45 kg/m2 and diagnosed with prediabetes.

Probably not a fit

Patients with clinical diagnoses of diabetes, eating disorders, or significant weight fluctuations may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the impact of time-restricted eating (TRE) on cardiometabolic health in individuals with obesity and prediabetes. Participants will follow a 9-hour eating window for 12 weeks without altering their body weight. The study aims to assess key metabolic outcomes, including insulin sensitivity and metabolic homeostasis, to better understand how TRE may influence cardiovascular disease risk factors. By comparing these outcomes, the trial seeks to clarify the potential benefits of TRE in improving metabolic health.

Why it matters

Potential benefit: If successful, this approach could provide a novel dietary strategy to improve metabolic health and reduce cardiovascular disease risk in patients with obesity and prediabetes.

How similar studies have gone: While there is limited research on time-restricted eating in humans, preliminary studies suggest potential benefits, indicating this approach is promising yet still under investigation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* must be able to grant voluntary informed consent and comply with the study instructions
* aged 25-75 years
* men and women
* body mass index 27-45 kg/m2
* fasting plasma glucose 5.6-6.9 mmol/L, or 2h oral glucose tolerance test plasma glucose 7.8-11.1 mmol/L or haemoglobin A1C 39-46 mmol/mol or homeostasis model assessment-insulin resistance (HOMA-IR) score ≥2.73
* self-reported habitual eating period ≥ 13 h per day

Exclusion Criteria:

* shift worker
* fasting \>12 h/day more than once a week
* vegan
* \> once a week no food intake after \~1800 h
* habitually waking up before \~0400 h and sleeping before \~2100 h
* unstable weight (\>5% change the last 2 months)
* Clinical diagnosis of type 1 or 2 diabetes
* Clinical diagnosis of sleep disorder
* Clinical diagnosis of eating disorder
* Clinical diagnosis of cancer in last 5 years
* conditions that render subject unable to complete all testing procedures (including individuals with known allergies or contraindications to the medications used in this study)
* use of medications that affect the study outcome measures or increase the risk of study procedures and that cannot be temporarily discontinued (e.g., steroids, alpha- or beta-adrenergic blockers or agonists, etc.)
* smoking and illegal drug use
* pregnant or lactating
* gastrointestinal or bariatric surgery (except cholecystectomy and appendectomy)
* individuals with electromedical devises
* prisoners
* alcohol abuse

Where it's running

  • Cambridge Clinical Research Center
    Cambridge, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.